bladder cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients over the age of 18 who signed the informed consent; 2. Those who were diagnosed with bladder cancer by cystoscopic biopsy or TURBT pathology before surgery; 3. Patients with indications for radical cystectomy after surgical evaluation; 4. No radiotherapy, chemotherapy and immunotherapy were performed before surgery; 5. The researcher estimates that the life expectancy of the patients is >= 6 months; 6. The patient agrees not to participate in other intervention studies during the treatment period.
Exclusion criteria
Exclusion criteria: The subjects have a history of serious diseases in the cardiovascular system, respiratory system, coagulation system or mental illness, and are judged by the investigator to be unsuitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anastomosis time for neobladder-urethra;Operation time;Urinary diversion time;Catheter removal time;Removal time of pelvic drainage tube;The restoration time of bowel functions;Postoperative stay;Maximum postoperative urinary flow rate;Postoperative residual urine volume;Incidence of anastomotic stenosis;Incidence of anastomotic leakage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative hemoglobin concentration;Intraoperative blood loss;Incidence of perioperative intestinal fistula;Incidence of perioperative infection;Incidence of perioperative intestinal obstruction;Incidence of uracratia; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Nanchang University